Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients
Status:
Unknown status
Trial end date:
2018-12-15
Target enrollment:
Participant gender:
Summary
Patients at least 18 years of age will be enrolled in the study to assess the efficacy and
tolerability of Picato gel in the treatment of molluscum contagiosum. Patients must have an
immunocompromised condition due to taking immunosuppressive drugs or having an inherited
disease affecting the immune system.